News Releases Home Synthetic Biology The History of Synthetic Biology Living Medicines Designing Synthetic Biotic™ Medicines Pipeline + Programs For Patients Our People Leadership Board of Directors Founders and Advisors Join Us Investors + Media Company Overview News & Events News Releases Event Calendar Presentations & Publications Stock Information Corporate Governance Financials Investor Resources Items Per Page 102550 Year None201920182017201620152014 March 23, 2017 Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting December 15, 2016 Synlogic Appoints COO and Head of Corporate Development November 10, 2016 Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia September 12, 2016 Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic August 29, 2016 Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation March 23, 2016 Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors February 17, 2016 Synlogic Secures $40 Million in Series B Financing February 10, 2016 Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome January 5, 2016 Synlogic to Present at the 34th Annual J.P. Morgan Healthcare Conference September 17, 2015 Synlogic Accelerates Business Growth with Appointment of President, Expansion of Financing, and an Industry Collaboration Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Next page next › Last page last » Displaying 81 - 90 of 94 Email Alerts Contact IR RSS Feeds Print Page Email Page
Items Per Page 102550 Year None201920182017201620152014 March 23, 2017 Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting December 15, 2016 Synlogic Appoints COO and Head of Corporate Development November 10, 2016 Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia September 12, 2016 Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic August 29, 2016 Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation March 23, 2016 Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors February 17, 2016 Synlogic Secures $40 Million in Series B Financing February 10, 2016 Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome January 5, 2016 Synlogic to Present at the 34th Annual J.P. Morgan Healthcare Conference September 17, 2015 Synlogic Accelerates Business Growth with Appointment of President, Expansion of Financing, and an Industry Collaboration Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Next page next › Last page last » Displaying 81 - 90 of 94
March 23, 2017 Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting
November 10, 2016 Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia
September 12, 2016 Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic
February 10, 2016 Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome
September 17, 2015 Synlogic Accelerates Business Growth with Appointment of President, Expansion of Financing, and an Industry Collaboration